Ország: Egyesült Királyság
Nyelv: angol
Forrás: VMD (Veterinary Medicines Directorate)
Enrofloxacin
Elanco Europe Ltd
QJ01MA90
Enrofloxacin
Solution for use in drinking water
POM-V - Prescription Only Medicine – Veterinarian
Chickens, Rabbits, Turkeys
Antimicrobial
Authorized
1993-11-11
Revised: October 2020 AN: 00860/2020 Page 1 of 6 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Baytril 10% Oral Solution 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One ml of Baytril 10% Oral Solution contains: ACTIVE SUBSTANCE Enrofloxacin 100 mg; EXCIPIENT(S) Benzyl alcohol 14 mg. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Solution for use in drinking water. Clear yellowish solution. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Chicken, turkey and rabbit. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Treatment of infections caused by the following bacteria susceptible to enrofloxacin: CHICKENS _Mycoplasma gallisepticum,_ _Mycoplasma synoviae,_ _Avibacterium paragallinarum,_ _Pasteurella multocida,_ TURKEY _Mycoplasma gallisepticum,_ _Mycoplasma synoviae,_ _Pasteurella multocida,_ RABBITS For the treatment infectious diseases due to _Pasteurella multocida_ and bacterial enteritis due to infection with _E.coli._ Revised: October 2020 AN: 00860/2020 Page 2 of 6 Enrofloxacin should be used where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the active substance of choice. 4.3 CONTRAINDICATIONS Do not use for prophylaxis. Do not use when resistance/ cross-resistance to (fluoro)quinolones is known to occur in the flock intended for treatment. Do not use in the case of known hypersensitivity to the active substance, other (fluoro)quinolones or to any of the excipients. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Treatment of _Mycoplasma spp_ infections may not eradicate the organism. 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS Official and local antimicrobial policies should be taken into account when the product is used. Fluoroquinolones should be reserved for the treatment of clinical conditions which have responded poorly, or are expected to respond poorly, to other classes of antimicrobials. Since enrofloxacin was first authorised for use in poul Olvassa el a teljes dokumentumot